# Post Market Surveillance to Observe Safety of Prevenar13™ in Adults

> **NCT01834222** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 659 (actual)

## Conditions studied

- Pneumococcal Disease

## Interventions

- **BIOLOGICAL:** Non-intervention

## Key facts

- **NCT ID:** NCT01834222
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 659 (ACTUAL)
- **Last updated:** 2017-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01834222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01834222, "Post Market Surveillance to Observe Safety of Prevenar13™ in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01834222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*